The document discusses various natural products with potential anticancer properties, focusing on their ability to inhibit telomerase activity. Quercetin, a polyphenolic compound found in many fruits and vegetables, is highlighted for its role in reducing telomerase activity, inducing apoptosis, and inhibiting cancer cell proliferation, making it a promising natural anticancer agent.
Quercetin has demonstrated significant anticancer properties in both in vitro and in vivo studies. Research indicates that quercetin induces apoptosis and inhibits proliferation across multiple cancer cell lines, including breast, colon, prostate, and lung cancers, by modulating pathways such as PI3K/Akt/mTOR and influencing proteins like p53 and BCL-2.
A randomized controlled trial investigated the effects of quercetin supplementation on telomere length in patients with type 2 diabetes mellitus (T2DM). The study found that quercetin intake was associated with a significant increase in mean telomere length, suggesting its potential as a beneficial supplement for individuals with T2DM.
The article explores quercetin’s primary pharmacological activities, including its antioxidant, anti-inflammatory, and anticancer properties, as well as its potential applications in clinical medicine for conditions such as cardiovascular diseases, neurodegenerative disorders, and cancer. It highlights quercetin’s therapeutic potential while addressing challenges related to its bioavailability and delivery methods.
Quercetin, a flavonoid abundant in various plant products, exhibits significant antioxidant, anti-inflammatory, anti-carcinogenic, and anti-diabetic properties. Its lipophilic nature allows it to cross the blood-brain barrier, offering neuroprotective effects against age-related diseases such as neurodegeneration, diabetes, cancer, and inflammation.
